Globus Medical Inc Class A GMED
NYSE · United States · Health Technology
$74.90-0.79 (-1.04%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | 1.34 | 1.10 | +21.9% | $789.61M | +0.9% | +2.2%$80.54→$82.35 |
| Q1 2026 | 2026-05-07 | 1.12 | 0.92 | +21.7% | — | — | -12.6%$89.22→$77.95 |
| Q4 2025 | 2026-02-24 | 1.28 | 1.15 | +11.3% | — | — | +3.0%$93.40→$96.22 |
| Q3 2025 | 2025-11-06 | 1.18 | 0.79 | +49.4% | — | — | +36.4%$61.51→$83.89 |
| Q4 2024 | 2025-02-20 | 0.84 | 0.75 | +12.0% | — | — | — |
| Q3 2024 | 2024-11-05 | 0.83 | 0.65 | +27.7% | — | — | — |
| Q4 2023 | 2024-02-20 | 0.60 | 0.61 | -1.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.